Simple. Reliable. Proven.
- Proven accurate DLCO measurements throughout the life of the unit.
- One DLCO measurement adds only 5 minutes to the test time.
- Immediate interpretation of results with the ATS/ERS decision tree.
- Close-to-patient diagnosis thanks to portable meter.
- TrueFlow technology used in clinical trials such as NIH, COPDGene, GOLD, NASA and World Trade Center.
DLCO readings provide important information for earlier and more accurate diagnosis:
As a differential diagnosis between asthma and emphysema and for monitoring patients with drug-induced pulmonary toxicity and as an early warning indicator of post-COVID complications. To predict severe exacerbations in COPD that could lead to hospitalisation or emergency admission. Diffusing capacity (DLCO) is the strongest predictor of survival in COPD patients. For early detection of interstitial lung disease, even before spirometry and lung volume values drop. DLCO measurements are an important diagnostic tool for COVID-19-related respiratory symptoms.
ndd TrueFlow
The original ultrasonic flow measurement is highly accurate in all flow ranges, independent of gas composition, pressure, temperature and humidity and does not require calibration during its
life-time. The sensor is never in direct contact with the patient‘s flow. ndd TrueFlow is a hygienic and resistance-free solution.
ndd TrueCheck
TrueCheck takes care of the essential quality control for gas analysis testing. EasyOne Pro is the only device proven to be accurate for a lifetime for DLCO measurements.
